- Home
- AVIR vs ARCI Comparison
AVIR vs ARCI Comparison
Compare AVIR & ARCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.03
Company Overview
Basic Information| Metric | AVIR | ARCI |
|---|---|---|
| Founded | 2012 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.3M | 354.4M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | AVIR | ARCI |
|---|---|---|
| Price | $4.03 | $10.06 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 283.4K | 74.4K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.78 | $9.83 |
| 52 Week High | $6.45 | $10.09 |
Technical Indicators
Market Signals| Indicator | AVIR | ARCI |
|---|---|---|
| Relative Strength Index (RSI) | 32.58 | 57.92 |
| Support Level | $3.31 | $9.83 |
| Resistance Level | $4.46 | N/A |
| Average True Range (ATR) | 0.27 | 0.01 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 5.74 | 62.50 |
Price Performance
Historical Comparison AVIR
ARCI
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About ARCI Archimedes Tech SPAC Partners III Co. Ordinary Share
Archimedes Tech SPAC Partners III Co is a blank check company.